CT scans may be better first step for evaluating chest pain

Previous studies have found less than 40% of patients with stable chest pain undergoing invasive coronary angiography are found to have obstructive coronary artery disease.

Mainz Biomed Announces Collaboration with Fugene Genetics in Israel – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 18.07.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

July 19, 2023

Innovations Powering the Future of mRNA: What Biomanufacturers Need to Know – Pharmaceutical Technology

Great opportunity has emerged for pharma firms with the rise of mRNA technology – but so too has potential risk. It isn’t often that pharmaceutical

November 10, 2023

ORLADEYO gains approval in Peru for HAE prevention

The once-daily oral capsule has been primarily developed to prevent HAE attacks. Credit: Kmpzzz/Shutterstock. Pint Pharma has announced the approval in Peru of Orladeyo (berotralstat)

July 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.